Cell Therapy Innovation Symposium 2024

The symposium will feature enlightening presentations from key opinion leaders on immunotherapy innovations and advancements in immune cell therapy manufacturing, including NK-cell based and T-cell based therapies. Engage in interactive discussions and network with academia and industry cell therapy experts during our evening mingle event.

Co-Chairs: Anna Pacetto, PhD, and Kalle Malmberg, PhD, Oslo University Hospital, Norway

12:00-12:30 Light lunch, soda and coffee served outside the auditorium

12:30-14:10 Session 1:

Non-viral strategies for CAR T engineering
Steven Feldman, PhD, Laboratory for Cell and Gene Medicine Stanford GMP Facility, US

Adoptive cell therapy for solid tumor up TIL now
Özcan Met, PhD, National Center for Cancer Immune Therapy, Herlev University Hospital, Denmark

Early phase manufacturing hurdles for an autologous T-Cell Therapy
Andrea Salmén, MSc, NEOGAP Therapeutics, Sweden

14:10-14:30 Coffee and snacks

14:30-16:10 Session 2:

A smoother path for tomorrow’s regenerative medicine
Jim Lund, PhD, CCRM Nordic

Development of allogeneic TCR-NK cell therapies for solid cancers
Anders Holm, PhD, Zelluna Immunotherapy, Norway

Applying flexible and scalable solutions to overcome cell therapy manufacturing challenges
Evan Zynda, PhD, Thermo Fisher Scientific, US

16:10-17:00 Light food and mingling outside the auditorium

17:00 End